Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Docetaxel, Vinorelbine, and Trastuzumab in HER2+ Metastatic Breast Cancer
NCT00193089Phase 2Completed
- Sponsor
- SCRI Development Innovations
- Start
- Apr 2001
- Primary completion
- Apr 2005
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of docetaxel in breast cancer, sponsored by SCRI Development Innovations. Started Apr 2001; status: completed.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00193089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00193089.